Peptides for Muscle Gain: What the Studies Show, Where the Data Runs Out, and How to Check a Claim

Sorting the compounds by the evidence behind them

Growth hormone secretagogues such as sermorelin and ipamorelin prompt the pituitary gland to release growth hormone. Look for human trials on PubMed and ClinicalTrials.gov, then check who enrolled. Some studies involve older adults or people with a diagnosed deficiency, which may not match a healthy lifter. Also ask whether the trial measured muscle mass or only hormone levels. A change in a blood marker tells you something about hormones, but it doesn't tell you how much muscle you'll gain.

BPC-157 and TB-500 follow a different pattern. Most of the data comes from rodent and cell models. Search both databases for human trial registrations and published results, and you'll likely find far fewer human studies than the marketing implies. The ones that exist tend to be small, so they can't carry the weight that sellers place on them.

IGF-1 analogs such as IGF-1 LR3 deserve extra caution. Published human data on them is sparse, and their regulatory status in Brazil should be checked before anyone discusses use. A forum thread won't answer that question for you.

Not everything sold beside peptides is a peptide. MK-677 is a nonpeptide ghrelin mimetic, so its chemistry and classification differ from the peptides listed next to it, and shops often blur that line. If you want a neutral place to learn how these categories are organized, PeptPro has guides on compound classes that can help you sort the terms before you read the papers.

What a useful human study actually looks like

A study that can tell you something about muscle usually has a randomized, placebo-controlled, blinded design. It needs enough participants and enough weeks for a real change to rise above the noise. Small, short, unblinded studies can generate interesting hypotheses, but they rarely settle a question. The Cochrane Handbook explains the general hierarchy of study designs and is a solid reference for judging what a trial can support.

Measurement matters as much as design. DXA and MRI estimate lean mass with far more precision than bathroom scales or bioimpedance devices, which react to hydration and recent meals. A tape measure shifts with posture and how hard you flex. A trial that reports only total body weight change tells you little about muscle, because weight moves with water and fat as well.

Strength and function count for more than a number on a scale. If a study shows a change in lean mass but no improvement in strength or performance, the result still matters, but it answers a narrower question than the advertising suggests. Check also who paid for the study, whether the authors disclose conflicts of interest, and whether the trial was registered before enrollment started. Registration lets you compare what researchers planned to measure with what they actually reported, which catches a lot of quiet outcome switching.

The lean mass question in GLP-1 drugs

Semaglutide and tirzepatide trials report weight loss, and the body composition data is more limited than many posts suggest. Only some of these trials measure body composition, often in a substudy with a smaller group. The STEP 1 publication for semaglutide, printed in the New England Journal of Medicine, is a good starting point, but pull the exact figures and the design details from the original papers rather than from secondary blogs, because summaries tend to flatten timing and methods.

Any weight loss, drug-assisted or not, can include some lean tissue loss. That's why resistance training and adequate protein intake show up so often in these trials. They appear in the study design for a reason, and they aren't decoration.

Two ideas need to stay separate. Preserving lean mass during a calorie deficit is one thing. Building new muscle is another. GLP-1 trials don't show that these drugs add muscle, and anyone who claims otherwise is stretching the data. These are approved medications with their own risk profile, and a prescriber has to weigh that profile for each patient. Treat them as a medical treatment, not as a muscle-building tool.

Doping rules and why athletes should care

The WADA Prohibited List places growth hormone, its releasing factors, and secretagogues under category S2. IGF-1 and its analogs appear in the same section as growth factors. The list is updated every year, so check the current edition instead of trusting an old forum post, and read the exact S2 wording, because the category names specific substances.

Athletes under testing rules can test positive even when a supplement label is unclear or incomplete. A seller who says “it's legal” tells you very little, since legal to sell and permitted in sport are separate questions. Products without quality control can also contain ingredients that don't match the label, which is one more reason to stay cautious.

Even if you never compete, the list works as a useful signal. A compound that a testing body bans in sport is one that the body considers performance-enhancing and risky. That should change how seriously you take a seller's marketing, whatever your goals are.

A checklist before you trust a muscle claim

• Check regulatory status and labeling. Confirm the product holds approval for human use in Brazil on Anvisa's consultation portal, that the registered name matches what you received, and that the label doesn't say “research use only” or “not for human consumption.” Those phrases point to weak supply chain control.
• Ask for a certificate of analysis from a third-party lab, then check that its batch number matches the vial or box in your hand. A certificate that doesn't match the product is no certificate at all.
• Compare the claim against the best human trial on PubMed, not against the seller's summary of that trial. If you can't find a human trial, you've learned something important.

Running through these steps takes only a few minutes, and it filters out most of the noise before you spend money. If you need background to make sense of each step, the beginner's guide to peptide categories on PeptPro covers the basics, so you can read a seller's claim next to what the trials actually tested.

What the basics still do most of the work

Progressive resistance training with a consistent weekly volume is the best-supported driver of muscle gain in the research literature. Adding load or repetitions over time matters more than any single exercise choice or supplement you'll see advertised.

Protein intake and total energy balance matter too. A widely cited meta-analysis by Morton and colleagues, published in the British Journal of Sports Medicine in 2018, found that the benefit of extra protein for people doing resistance training leveled off at intakes around 1.6 grams per kilogram of body weight per day. Sleep deserves a short mention, because poor sleep tends to undermine recovery and training quality.

Any peptide study should be judged against a control group that does the same training and eats the same diet. In many trials, the control arm gains a meaningful amount, and that baseline is where much of the change comes from. Put the peptide result next to that control group, not next to zero.

If you want to keep learning, our peptide guides on PeptPro explain study design and compound categories in plain language. That's a practical next step once you've run the checklist, because it helps you read the next muscle claim with the same skepticism.

FAQ

Do peptides build muscle?

Some peptides have human data, but for most muscle claims the evidence is thin or missing. Resistance training and adequate protein remain the best-supported drivers of muscle gain.

Are peptides legal for muscle building in Brazil?

It depends on the specific compound and on whether it holds a registration. Check Anvisa's consultation portal, and remember that a product sold online may have no registration at all.

Does semaglutide cause muscle loss?

Some trials show that part of the weight lost during treatment is lean tissue, alongside fat loss. Resistance training and adequate protein are commonly studied alongside these drugs. Discuss any concerns about lean mass with a prescriber.

Sources

• WADA Prohibited List
• ClinicalTrials.gov
• PubMed, National Library of Medicine
• Anvisa Consultas (registered products portal)
• Morton et al., Protein supplementation and resistance training meta-analysis, British Journal of Sports Medicine (2018)
• Wilding et al., Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), New England Journal of Medicine
• Cochrane Handbook for Systematic Reviews of Interventions
• StatPearls: Physiology, Growth Hormone (NCBI Bookshelf)